SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001171843-20-002413
Filing Date
2020-04-06
Accepted
2020-04-06 17:01:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 f424b3_040320.htm 424B3 185366
2 GRAPHIC clinical.jpg GRAPHIC 23786
  Complete submission text file 0001171843-20-002413.txt   219352
Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
Seneca Biopharma, Inc. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-236543 | Film No.: 20777620
SIC: 2836 Biological Products, (No Diagnostic Substances)